Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Infections in patients with rheumatoid arthritis treated with biologic agents.
Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A. Listing J, et al. Among authors: herzer p. Arthritis Rheum. 2005 Nov;52(11):3403-12. doi: 10.1002/art.21386. Arthritis Rheum. 2005. PMID: 16255017
Treatment continuation in patients receiving biological agents or conventional DMARD therapy.
Zink A, Listing J, Kary S, Ramlau P, Stoyanova-Scholz M, Babinsky K, von Hinueber U, Gromnica-Ihle E, Wassenberg S, Antoni C, Herzer P, Kekow J, Schneider M, Rau R. Zink A, et al. Among authors: herzer p. Ann Rheum Dis. 2005 Sep;64(9):1274-9. doi: 10.1136/ard.2004.031476. Epub 2005 Feb 11. Ann Rheum Dis. 2005. PMID: 15708884 Free PMC article.
Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs.
Strangfeld A, Richter A, Siegmund B, Herzer P, Rockwitz K, Demary W, Aringer M, Meißner Y, Zink A, Listing J. Strangfeld A, et al. Among authors: herzer p. Ann Rheum Dis. 2017 Mar;76(3):504-510. doi: 10.1136/annrheumdis-2016-209773. Epub 2016 Jul 12. Ann Rheum Dis. 2017. PMID: 27405509 Free PMC article.
61 results